Proteolytic events of wound-healing - Coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules

Critical Reviews in Oral Biology and Medicine

Volumn 12, Issue 5, 2001, Pages 373-398

  Steffensen, Bjorn ^a   Häkkinen, Lari ^b   Larjava, Hannu ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Extracellular matrix; Integrins; Matrix metalloproteinases; MMP; Wound healing

Indexed keywords

GELATINASE A; INTEGRIN; MATRIX METALLOPROTEINASE; SCLEROPROTEIN;

ARTICLE; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL SURFACE; CONNECTIVE TISSUE; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FIBROBLAST; KERATINOCYTE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; WOUND HEALING;

EID: 0034764101     PISSN: 10454411     EISSN: None     Source Type: Journal    
DOI: 10.1177/10454411010120050201     Document Type: Article

References (341)

1. Protein engineering of the 72-kDa gelatinase collagen binding domain
2. Gelatinase activity during wound healing
3. Matrix metalloproteinases (MMPs) are required for re-epithelialization of cutaneous wounds
4. The alpha v beta 6 integrin induces gelatinase B secretion in colon cancer cells
5. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3
6. Signal transduction and signal modulation by cell adhesion receptors: The role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins
7. Cell adhesion molecules, signal transduction and cell growth
8. Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans
9. Fibrillin degradation by matrix metalloproteinases: Implications for connective tissue remodelling
10. r 72,000 type IV collagenase in normal and malignant human fibroblastoid cells
11. Purification and characterization of an acid metalloproteinase from human articular cartilage
12. Evidence for the involvement of type II domains in collagen binding by 72 kDa type IV procollagenase
13. The gelatin-binding site of human 72 kDa type IV collagenase (gelatinase A)
14. Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin
15. Molecular cloning and mRNA tissue distribution of a novel matrix metalloproteinase isolated from porcine enamel organ
16. Focalized proteolysis: Spatial and temporal regulation of extracellular matrix degradation at the cell surface
17. Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter
18. Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix
19. Autolytic activation of recombinant human 72 kilodalton type IV collagenase
20. Fragments of human fibroblast collagenase: Interaction with metalloproteinase inhibitors and substrates
21. Specific, high-affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH terminal hemopexin-like domain of human gelatinase A: TIMP-4 binds progelatinase A and the COOH terminal domain in a similar manner to TIMP-2
22. Role of matrix metalloproteinases in human periodontal diseases
23. Detergent-activation of latent collagenase and resolution of its component molecules
24. Matrix metalloproteinases: A review
25. Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues
26. Integrin α2β1-dependent contraction of floating collagen gels and induction of collagenase are inhibited by tyrosine kinase inhibitors
27. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3
28. r 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines
29. Cellular activation of the 72 kDa type IV procollagenase/TIMP-2 complex
30. Loss of fibrinogen rescues mice from pleiotropic effects of plasminogen deficiency
31. Impaired wound contraction in stromelysin-1 deficient mice
32. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases
33. The TIMP-2 membrane type I metalloproteinase receptor regulates the concentration and efficient activation of progelatinase A. A kinetic study
34. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation
35. The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A
36. Gene targeting and gene transfer studies of the plasminogen/plasmin system: Implications in thrombosis, hemostasis, neointirna formation, and atherosclerosis
37. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
38. Primary structure and cDNA cloning of human fibroblast collagenase inhibitor
39. Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125(FAK), paxillin, and talin
40. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein
41. Proteases associated with invadopodia, and their role in degradation of extracellular matrix
42. Regulation of extracellular matrix synthesis by mechanical stress
43. Tenascin-C expression by fibroblasts is elevated in stressed collagen gels
44. Enhanced expression of neural cell adhesion molecules and tenascin (Cytotactin) during wound healing
45. Fragments of human fibroblast collagenase. Purification and characterization
46. Re-epithelialization of normal human excisional wounds is associated with a switch from αvβ5 to αvβ6 integrins
47. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen
48. Alanine scanning mutagenesis and functional analysis of the fibronectin-like collagen-binding domain from human 92-kDA type IV
49. Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism
50. Identification of MMP-18, a putative novel human matrix metalloproteinase
51. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases
52. Signal transduction via the fibronectin receptor: Do integrins regulate matrix remodeling?
53. Affinity of integrins for damaged extracellular matrix: Alpha v beta 3 binds to denatured collagen type I through RGD sites
54. Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells
55. Cloning of MMP-26. A novel matrilysin-like proteinase
56. Integrins: Alternative splicing as a mechanism to regulate ligand binding and integrin signaling events
57. Keratinocyte migration requires α2β1 integrin-mediated interaction with the laminin-5 gamma2 chain
58. Actin cytoskeleton organization in response to integrin-mediated adhesion
59. Epidermal expression of collagenase delays wound-healing in transgenic mice
60. 2-macroglobulin by cultured fibroblasts
61. Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength
62. Interaction among collagenase-1, collagen, and the integrin α2β1 during re-epithelialization
63. Pro-collagenase-1 (matrix metalloproteinase-1) binds the alpha 2beta 1 integrin upon release from keratinocytes migrating on type I collagen
64. The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth
65. Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin
66. Regulation of the spatial organization of mesenchymal connective tissue: Effects of cell-associated versus released isoforms of platelet-derived growth factor
67. Cell surface binding of TIMP-2 and pro-MMP-2/TIMP-2 complex
68. r 72,000 type IV collagenase
69. Primary structure of PDC-109, a major protein constituent of bovine seminal plasma
70. Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat
71. Extracellular matrix regulation of growth factor and protease activity
72. The extracellular regulation of growth factor action
73. Beta1C integrin in epithelial cells correlates with a nonproliferative phenotype: Forced expression of beta1C inhibits prostate epithelial cell proliferation
74. Degradation of cartilage aggrecan by collagenase-3 (MMP-13)
75. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures
76. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas
77. Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions
78. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
79. Release of biological activities from quiescent fibronectin by a conformational change and limited proteolysis by matrix metalloproteinases
80. Collagenolytic activity in gingivae of man
81. Studies in vitro on the role of αv and β1 integrins in the adhesion of human dermal fibroblasts to provisional matrix proteins fibronectin, vitronectin, and fibrinogen
82. Expression of functional α4β1 integrin by human dermal fibroblasts
83. TGF-β1 stimulates expression of keratinocyte integrins during re-epithelialization of cutaneous wounds
84. Platelet-derived growth factor and inflammatory cytokines have differential effects on the expression of integrins α1β1 and α5β1 by human dermal fibroblasts in vitro
85. Human fibroblasts bind directly to fibrinogen at RGD sites through integrin αvβ3
86. Absence of integrin alpha1beta1 in the mouse causes loss of feedback regulation of collagen synthesis in normal and wounded dermis
87. Overview of matrix metalloproteinase expression in cultured human cells
88. Integrin signaling: Specificity and control of cell survival and cell cycle progression
89. Integrin signaling
90. Induction of cell migration by matrix metalloproteinase-2 cleavage of laminin-5
91. Expression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids
92. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2
93. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin
94. Processing of laminin-5 and its functional consequences: Role of plasmin and tissue-type plasminogen activator
95. The α3 laminin subunit, α6β4 and α3β1 integrin coordinately, regulate wound healing in cultured epithelial cells and in the skin
96. Overview of expression of matrix metalloproteinases (MMP-17, MMP-18, and MMP-20) in cultured cells
97. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4
98. Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix
99. Identification of neutrophil elastase as the proteinase in burn wound fluid responsible for degradation of fibronectin
100. Degradation of fibronectin and vitronectin in chronic wound fluid: Analysis by cell blotting, immunoblotting, and cell adhesion assays
101. Release of mechanical tension triggers apoptosis of human fibroblasts in a model of regressing granulation tissue
102. Urokinase and tissue-type plasminogen activators in keratinocytes during wound re-epithelialization in vivo
103. Collagenolytic activity in amphibian tissues: A tissue culture assay
104. Specific degradation of the collagen molecule by tadpole collagenolytic enzyme
105. Isolation and characterization of two novel metalloproteinase genes linked to the Cdc2L locus on human chromosome 1p36.3
106. Keratinocytes in human wounds express αvβ6 integrin
107. Altered interaction of human granulation-tissue fibroblasts with fibronectin is regulated by α5β1 integrin
108. Cell biology of gingival wound healing
109. Immunolocalization of tenascin-C, α9 integrin subunit and αvβ6 integrin during wound healing in human oral mucosa
110. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase
111. Integrin associated proteins
112. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins
113. Structure-function relationship of human neutrophil collagenase: Identification of regions responsible for substrate specificity and general proteinase activity
114. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover
115. Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture
116. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinase-2
117. Integrin signaling and cell growth control
118. Normal development, wound healing, and adenovirus susceptibility in beta5-deficient mice
119. Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92-and 72-kilodalton enzyme genes in HT-1080 cells
120. Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin
121. Degradation of vitronectin by matrix metalloproteinases-1, -2, -3, -7 and -9
122. Degradation of decorin by matrix metalloproteinases: Identification of the cleavage sites, kinetic analyses and transforming growth factor-β1 release
123. Collagenase expression is rapidly induced in wound-edge keratinocytes after acute injury in human skin, persists during healing, and stops at re-epithelialization
124. Integrin alpha2beta1 mediates isoform-specific activation of p38 and upregulafton of collagen gene transcription by a mechanism involving the alpha2 cytoplasmic tail
125. Nucleotide sequence and organization of the human S-protein gene: Repeating peptide motifs in the "pexin" family and a model for their evolution
126. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase
127. Functional significance of CD9 association with beta 1 integrins in human epidermal keratinocytes
128. Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth
129. Regulation of extracellular matrix proteins and integrin cell substratum adhesion receptors on epithelium during cutaneous human wound healing in vivo
130. Cooperation between soluble factors and integrin-mediated cell anchorage in the control of cell growth and differentiation
131. Matrix metalloproteinases in skin
132. Essential role of laminin-5 during re-epithelialization of wounds
133. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration
134. Fibronectin and fibronectin fragments modulate the expression of proteinases and proteinase inhibitors in human periodontal ligament cells
135. The response of periodontal ligament cells to fibronectin
136. Mutations in the heparin binding domain of fibronectin in cooperation with the V region induce decreases in pp125(FAK) levels plus proteoglycan-mediated apoptosis via caspases
137. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells
138. Utilization of transgenic mice in the study of matrix degrading proteinases and their inhibitors
139. Vitronectin-driven human keratinocyte locomotion is mediated by the αvβ5 integrin receptor
140. Identification and characterization of human tissue inhibitor of metalloproteinase-3 and detection of three additional metalloproteinase inhibitor activities in extracellular matrix
141. Matrix metalloproteinases and metastasis
142. Biochemical characterization of human collagenase-3
143. Cellular mechanisms for human procollagenase-3 (MMP-13). Activation
144. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction
145. Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13)
146. Different integrins mediate cell spreading, haptotaxis and lateral migration of HaCat keratinocytes on fibronectin
147. Isometric contraction by fibroblasts and endothelial cells in tissue culture: A quantitative study
148. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5
149. Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins
150. Anti-integrin antibodies induce type IV collagenase expression in keratinocytes
151. Expression of integrins and basement membrane components by wound keratinocytes
152. Keratinocyte integrins in wound healing and chronic inflammation of the human periodontium
153. Bidirectional transmembrane modulation of integrin alpha IIb beta 3 conformations
154. Early expression of a collagenase-like hatching enzyme gene in the sea urchin embryo
155. Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1
156. Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells
157. Crystal structure of the hemopexin-like C-terminal domain of gelatinase A
158. Tumor invasion and metastasis: An imbalance of positive and negative regulation
159. Identification and structural and functional characterization of human enamelysin (MMP-20)
160. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase A overexpressed in brain tumors
161. Cloning of the bovine 215-kDa cation-independent mannose 6-phosphate receptor
162. Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury
163. ECM signalling: Orchestrating cell behaviour and misbehaviour
164. Functional overlap between two classes of matrix-degrading proteases in wound healing
165. Amino acid sequence of the heavy chain of human alpha-factor XIIa (activated Hageman factor)
166. Differential expression of matrix metalloproteinases and their physiological inhibitors in acute murine skin wounds
167. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair
168. The intracellular functions of alpha6beta4 integrin are regulated by EGF
169. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: Cellular origin and relationship to periodontal status
170. MMP-9 from TNFα-stimulated keratinocytes binds to cell surface and type I collagen
171. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes
172. Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin
173. Actin cables and epidermal movement in embryonic wound healing
174. The matrix-degrading metalloproteinases
175. Differential expression of tenascin splicing variants in the chick gizzard and in cell cultures
176. Collagenase gene expression in fibroblasts is regulated by a three-dimensional contact with collagen
177. Transforming growth factor-beta 1 is a heparin-binding protein: Identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-beta 1
178. Inflammation dampened by gelatinase-A cleavage of monocyte chemoattractant protein-3
179. Effects of collagenase-cleavage of type I collagen on alpha2beta1 integrin-mediated cell adhesion
180. Cloning, expression and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage
181. Fibronectin and integrins in cell adhesion, signaling, and morphogenesis
182. Stress relaxation of contracted collagen gels: Disruption of actin filament bundles, release of cell surface fibronectin and down-regulation of DNA and protein synthesis
183. r 72,000 matrix metalloproteinase at cell surface invadopodia
184. Insulin-like growth factor II receptor as a multifunctional binding protein
185. SPARC (osteonectin/BM-40)
186. Latent transforming growth factor-beta: Structural features and mechanisms of activation
187. Interactions between growth factors and integrins: Latent forms of transforming growth factor-β are ligands for the integrin αvβ1
188. The integrin αvβ6 binds and activates latent TGF-β1: A mechanism for regulating pulmonary inflammation and fibrosis
189. Proteolysis and cell migration: Creating a path?
190. Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes
191. The role of the C-terminal domain in collagenase and stromelysin specificity
192. The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases
193. Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant
194. Stepwise activation of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl) mercuric acetate
195. Partial purification and characterization of a neutral proteinase with collagen telopeptidase activity produced by human gingival fibroblasts
196. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion
197. Matrix metalloproteinases: Biologic activity and chemical implications
198. Human and rat malignant-tumor-associated mRNAs encode stromelysin-like metalloproteinases
199. Integrin-mediated signalling of gelatinase B secretion in colon cancer cells
200. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9
201. Membrane type 1 metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules
202. Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: Variable expression in various blistering diseases, induction during re-epithelialization, and decrease by topical glucocorticoids
203. Expression of matrix metalloproteinases during rat skin wound healing: Evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A
204. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties
205. Identification and characterization of enamel proteinases isolated from developing enamel
206. Initial characterization of a neutral metalloproteinase, active on native 3/4-collagen fragments, synthesized by ROS 17/2.8 osteoblastic cells, periodontal fibroblasts, and identified in gingival crevicular fluid
207. Concanavalin-A produces a matrix-degradative phenotype in human fibroblasts. Induction/endogenous activation of collagenase, 72 kDa gelatinase, and PUMP-1 is accompanied by suppression of tissue inhibitor of matrix metalloproteinases
208. Reciprocal regulation of collagenase, 72 kDa gelatinase and TIMP gene expression and protein synthesis in human fibroblasts induced by concanavalin A
209. Substrate and TIMP interactions with human gelatinase A recombinant COOH-terminal hemopexin-like and fibronectin type II-like domains: Both the N- and C-domains of TIMP-2 bind the C-domain of gelatinase A
210. Integrin dynamics on the tail region of migrating fibroblasts
211. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness
212. Physical and biochemical regulation of integrin release during rear detachment of migrating cells
213. Kinetic model for integrin-mediated adhesion release during cell migration
214. Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor
215. Localization and activation of type IV collagenase/gelatinase at endothelial focal contacts
216. Leukolysin/MMP25/MT6-MMP: A novel matrix metalloproteinase specifically expressed in the leukocyte lineage
217. Furin-dependent intracellular activation of the human stromelysin-3 zymogen
218. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity
219. Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution
220. Enhanced synthesis of collagenase by human keratinocytes cultured on type I or type IV collagen
221. The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix
222. Collagenase-1 and collagen in epidermal repair
223. Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity
224. Cathepsin G-induced release of PAI-1 in the culture medium of endothelial cells: A new thrombogenic role for polymorphonuclear leukocytes?
225. Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading
226. Distinct localizations of urokinase-type plasminogen activator and its type I inhibitor under cultured human fibroblasts and sarcoma cells
227. Relation between substrate specificity and domain structure of 92-kDa type IV collagenase
228. Elevated matrix metalloproteinase and angiostatin levels in integrin α1 knockout mice cause reduced tumor vascularization
229. Localization during development of alternatively spliced forms of cytotactin mRNA by in situ hybridization
230. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma
231. Keratinocyte growth factor (KGF) promotes keratinocyte cell attachment and migration on collagen and fibronectin
232. Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization
233. A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin
234. Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members
235. The cutaneous microfibrillar apparatus contains latent transforming growth factor-beta binding protein-1 (LTBP-1) and is a repository for latent TGF-beta1
236. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors
237. Induction of collagenase-3 in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase
238. Transforming growth factor-β induces collagenase-3 (MMP-13) expression by human gingival fibroblasts via p38 mitogen-activated protein kinase
239. Differential expression of SPARC and thrombospondin 1 in wound repair: Immunolocalization and in situ hybridization
240. Dynamics of beta 1 integrin-mediated adhesive contacts in motile fibroblasts
241. Plasmin abrogates alpha v beta 5-mediated adhesion of a human keratinocyte cell line (HaCaT) to vitronectin
242. Transforming growth factor-beta regulates collagen gel contraction by increasing alpha 2 beta 1 integrin expression in osteogenic cells
243. Integrin α2β1 is a positive regulator of collagenase (MMP-1) and collagen α1(I) gene expression
244. Transforming growth factor-beta
245. Impaired wound healing in mice with a disrupted plasminogen gene
246. Increased c-fos mRNA expression by human fibroblasts contracting stressed collagen matrices
247. Fibronectin and its integrin receptors in cancer
248. Extracellular matrix/growth factor interactions
249. Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers
250. Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing
251. Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds
252. Interstitial collagenase is expressed by keratinocytes that are actively involved in re-epithelialization in blistering skin diseases
253. The fibronectin extra domain A activates matrix metalloproteinase gene expression by an interleukin-1-dependent mechanism
254. Expression of matrix metalloproteinase-2 and -9 during early human wound healing
255. Structure-function relationships in the collagenase family member transin
256. Computational sequence analysis of matrix metalloproteinases
257. A matrix metalloproteinase expressed on the surface of invasive tumor cells
258. Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts
259. Plasminogen activation in healing human wounds
260. Integrin alpha 2 beta 1 (VLA-2) mediates reorganization and contraction of collagen matrices by human cells
261. The recombinant catalytic domain of human neutrophil collagenase lacks type I collagen substrate specificity
262. Motogenic activity of IGD-containing synthetic peptides
263. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism
264. A fine structural comparison of the healing of incisional wounds of mucosa and skin
265. A matrix metalloproteinase inhibitor which prevents fibroblast-mediated collagen lattice contraction
266. 3 integrin in human melanoma cell invasion
267. 3 and α5β1 integrins during human melanoma cell invasion
268. Complete amino acid sequence of BSP-A3 from bovine seminal plasma. Homology to PDC-109 and to the collagen-binding domain of fibronectin
269. Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction
270. Matrix metalloproteinase degradation of extracellular matrix: Biological consequences
271. Cell migration by graded attachment to substrates and contraction
272. The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type H-like repeats
273. Role of integrins in cellular responses to mechanical stress and adhesion
274. Cellular and extracellular biology of the latent transforming growth factor-beta binding proteins
275. Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases
276. Matrix metalloproteinases in periodontal remodelling
277. Integrin α6/β4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion
278. Human fibroblast collagenase-alpha-macroglobulin interactions. Localization of cleavage sites in the bait regions of five mammalian alpha-macroglobulins
279. 73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation
280. The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin
281. Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen
282. The involvement of the fibronectin type II-like modules of human gelatinase A in cell surface localization and activation
283. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family
284. Tumor cell interactions with the extracellular matrix during invasion and metastasis
285. Extracellular matrix remodelling and cellular differentiation
286. Localization of mRNAs representing collagenase and TIMP in sections of healing human burn wounds
287. Localization of mRNAs representing interstitial collagenase, 72 kDa gelatinase, and TIMP in healing porcine bum wounds
288. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease
289. Modulation of intracellular calcium levels inhibits secretion of collagenase 1 by migrating keratinocytes
290. Induction and repression of collagenase-1 by keratinocytes is controlled by distinct components of different extracellular matrix compartments
291. cDNA and amino acid sequences of the cell adhesion protein receptor recognizing vitronectin reveal a transmembrane domain and homologies with other adhesion protein receptors
292. Growth factors in the extracellular matrix
293. Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils
294. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family
295. Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains
296. Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton
297. Rapid and reversible regulation of collagen XII expression by changes in tensile stress
298. Fibronectin fragments, but not intact fibronectin, signalling through the fibronectin receptor induce metalloproteinase gene expression in fibroblasts
299. SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway
300. The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts
301. Components of the nuclear signaling cascade that regulate collagenase gene expression in response to integrin-derived signals
302. Type IV collagenases in invasive tumors
303. Extracellular matrix molecules and their receptors: An overview with special emphasis on periodontal tissues
304. Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds
305. Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds
306. Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3 and -4) in normal and aberrant wound healing
307. Demonstration of an 2-macroglobulin receptor in human fibroblasts. Absent in tumor-derived cell lines
308. The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family
309. Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members
310. 2+ for fibronectin and heparin binding: Binding properties of recombinant gelatinase A C-domain to extracellular matrix and basement membrane components
311. Expression, purification and characterization of recombinant mouse MT5-MMP protein products
312. Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes
313. The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1
314. Cell surface-mediated activation of progelatinase A: Demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts
315. Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction
316. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression
317. Expression and function of matrix metalloproteinases in development
318. A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation,
319. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages
320. cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment
321. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: A kinetic analysis of the inhibition of gelatinase A
322. An internal cysteine plays a role in the maintenance of the latency of human fibroblast collagenase
323. Matrix metalloproteinases and their inhibitors in connective tissue remodeling
324. The family of matrix metalloproteinases
325. Breast-cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing
326. Re-epithelialization
327. Laminin inhibits human keratinocyte migration
328. Fibronectin profiles in normal and chronic wound fluid
329. Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases: Stromelysin plays a major role in chondrolysis
330. Extracellular matrix alters PDGF regulation of fibroblast integrins
331. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: Dependence on extracellular matrix components
332. Cell adhesion receptors for native and denatured type I collagens and fibronectin in rabbit arterial smooth muscle cells in culture
333. Identification of integrins involved in cell adhesion to native and denatured type I collagens and the phenotypic transition of rabbit arterial smooth muscle cells
334. Salivary EGF regulates eosinophil-derived TGF-alpha expression in hamster oral wounds
335. Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing
336. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction
337. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis
338. Laminin 5 deposition promotes keratinocyte motility
339. Enrichment of collagen and gelatin degrading activities in the plasma membranes of human cancer cells